Z

Serial Number 87977224
Registration 5471551
702

Registration Progress

Application Filed
Oct 5, 2016
Under Examination
Apr 18, 2017
Approved for Publication
Feb 21, 2017
Published for Opposition
Feb 21, 2017
Registered
May 15, 2018

Trademark Image

Z

Basic Information

Serial Number
87977224
Registration Number
5471551
Filing Date
October 5, 2016
Registration Date
May 15, 2018
Published for Opposition
February 21, 2017
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Aug 30, 2024
Registration
Registered
Classes
005

Rights Holder

Pacira Therapeutics, Inc.

03
Address
Lincoln Center Suite 890 5401 West Kennedy Blvd.
Tampa, FL 33603

Ownership History

Flexion Therapeutics, Inc.

Original Applicant
03
Burlington, MA

Flexion Therapeutics, Inc.

Owner at Publication
03
Burlington, MA

Pacira Therapeutics, Inc.

Original Registrant
03
Tampa, FL

Pacira Therapeutics, Inc.

New Owner After Registration #1
03
Tampa, FL

Legal Representation

Attorney
Keith Toms, Esq.

USPTO Deadlines

Next Deadline
872 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20180515)
Due Date
May 15, 2028
Grace Period Ends
November 15, 2028

Application History

39 events
Date Code Type Description Documents
Aug 30, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Aug 30, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Aug 30, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Feb 12, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
May 15, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Apr 19, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 23, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 9, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jan 26, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Oct 15, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 15, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 15, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 10, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 9, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 30, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 30, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 29, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 23, 2018 IUAF S USE AMENDMENT FILED Loading...
Mar 29, 2018 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Mar 23, 2018 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Mar 29, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 23, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 29, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 23, 2018 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Mar 23, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 23, 2018 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 20, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 18, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 18, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 18, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 18, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 21, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 21, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 1, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 12, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 12, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 13, 2016 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 12, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 8, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, injectable pain therapeutics; pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis; analgesic and anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for injection for medical purposes for the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis; drug delivery agents in the form of dissolvable microspheres that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds, being a component in pharmaceutical preparations, that facilitate delivery of a wide range of pharmaceuticals
First Use Anywhere: 20171100
First Use in Commerce: 20171100

Additional Information

Design Mark
The mark consists of two lines of dots, side by side, in the shape of the letter "Z".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005